NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Given New C$5.50 Price Target at CIBC

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its price objective lowered by CIBC from C$5.75 to C$5.50 in a research report released on Thursday morning, BayStreet.CA reports.

Several other equities analysts have also issued reports on NWH.UN. BMO Capital Markets raised their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.25 and gave the stock a market perform rating in a report on Monday, May 27th. National Bankshares upped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.25 to C$5.75 and gave the stock a sector perform rating in a research report on Thursday, May 16th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, NorthWest Health Prop Real Est Inv Trust has a consensus rating of Hold and an average target price of C$6.43.

NorthWest Health Prop Real Est Inv Trust Stock Up 0.6 %

NWH.UN stock traded up C$0.03 during trading on Thursday, hitting C$4.85. 655,853 shares of the company’s stock were exchanged, compared to its average volume of 552,410. The business has a 50-day moving average price of C$4.89 and a two-hundred day moving average price of C$4.80. The company has a current ratio of 0.19, a quick ratio of 0.06 and a debt-to-equity ratio of 128.43. The stock has a market capitalization of C$1.19 billion, a price-to-earnings ratio of -3.95, a PEG ratio of 0.74 and a beta of 1.05. NorthWest Health Prop Real Est Inv Trust has a 52-week low of C$3.89 and a 52-week high of C$7.08.

NorthWest Health Prop Real Est Inv Trust Company Profile

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.